Evidence browser
Explore the evidence
Loading the evidence…
Evidence browser
Loading the evidence…
Evidence browser
35,993 claims
DEBRA's charitable expenditure decreased by 13% in 2024 compared to the previous year.
We spent £3.8m on charitable activities in 2024, compared with £4.4m in 2023, a 13% decrease.
Financial · Observational claim · From Debra — annual report and accounts, year ending 31 December 2024, page 38
DEBRA aims to build a lean, efficient, and sustainable retail function as part of its expansion strategy.
To build a lean, efficient, and sustainable retail function as a basis for expansion.
Operational · Policy statement · From Debra — annual report and accounts, year ending 31 December 2024, page 30
DEBRA plans to raise £2.5m of incremental funding through collaborative efforts with partners and major donors.
To fast-track funding to support our drug repurposing programme we will work collaboratively with partners and major donors to raise £2.5m of incremental funding.
Financial · Commitment statement · From Debra — annual report and accounts, year ending 31 December 2024, page 29
DEBRA aims to significantly grow its individual giving revenue from £500,000 per annum.
Following the appointment of a dedicated Individual Giving Manager in 2024 we will execute a data focused individual giving strategy that aims to increase the number of people who regularly support the charity and the amount that they give. The objective will be to significantly grow our existing revenue from £500,000 per annum through individual giving.
Financial · Policy statement · From Debra — annual report and accounts, year ending 31 December 2024, page 29
DEBRA saw a significant increase in the number of people supporting the charity, driven by PR and media coverage.
2024 saw a significant increase in the number of people choosing to support DEBRA, much of this was driven by the PR and media coverage generated from the 2023 English Channel swim challenge.
Relational · Observational claim · From Debra — annual report and accounts, year ending 31 December 2024, page 26
DEBRA aims to grow its core net fundraising income to £3.6m in 2025.
To grow our core net fundraising income to £3.6m in 2025.
Financial · Commitment statement · From Debra — annual report and accounts, year ending 31 December 2024, page 26
DEBRA has renewed its research partnerships and entered a new partnership with NHS England.
In 2024 we renewed our existing research partnerships and entered a new partnership with NHS England:
Commissioning · Procedural statement · From Debra — annual report and accounts, year ending 31 December 2024, page 21
DEBRA will explore initiatives to provide tailored mental health support for the EB community due to inadequate NHS provision.
Because our members have told us that the current mental health support available to them through the NHS is inadequate, we will continue to explore initiatives to provide tailored mental health support for the EB community.
Service · Commitment statement · From Debra — annual report and accounts, year ending 31 December 2024, page 18
DEBRA plans to increase overall membership by 10% in 2025, with a focus on recruiting new members with EB Simplex (EBS).
Our objective in 2025 is to increase overall DEBRA membership by 10% with a particular focus on recruiting new members with EBS.
Commissioning · Commitment statement · From Debra — annual report and accounts, year ending 31 December 2024, page 18
DEBRA aims to ensure that everyone with Epidermolysis Bullosa (EB) has access to the best care and specialist expertise from diagnosis onwards.
We are dedicated to ensuring that everyone with EB has access to the best care and specialist EB healthcare expertise and wellbeing support from diagnosis onwards.
Policy · Policy statement · From Debra — annual report and accounts, year ending 31 December 2024, page 14
DEBRA continues to partner with NHS England and other organizations to improve EB healthcare data analysis.
Our new partnership with the NHS England National Disease Registration Service will continue to develop with a focus on understanding the healthcare landscape for people living with EB. We will work to identify gaps in care, analyse healthcare trends, and deliver actionable insights that can inform future healthcare policies and research agendas for EB.
Commissioning · Procedural statement · From Debra — annual report and accounts, year ending 31 December 2024, page 12
DEBRA aims to fund science of the highest quality across the world, prioritizing drug repurposing and supporting early-career researchers.
We are one of the largest funders of EB research, and we have an ambitious, patient-centred research strategy that drives us to fund science of the highest quality across the world, including prioritising investment in drug repurposing, investing in the next generation of EB researchers to develop a treatment pipeline that will slow or stop the progression of all forms of EB.
Research · Policy statement · From Debra — annual report and accounts, year ending 31 December 2024, page 9
DEBRA has invested over £22 million in EB research since its founding.
During this time, we have invested over £22m and been responsible for establishing much of what is now known about EB.
Financial · Observational claim · From Debra — annual report and accounts, year ending 31 December 2024, page 9
DEBRA raised £4 million through the 'BE the difference for EB' appeal, despite challenges faced by their Vice President and swim team.
Despite our Vice President, Graeme Souness CBE, and the swim team being unable to take on their fundraising challenge, thanks to our many supporters we still managed to raise an impressive £4m.
Financial · Observational claim · From Debra — annual report and accounts, year ending 31 December 2024, page 7
DEBRA awarded more member support grants in 2024, with a total of 552 grants representing a 30% increase from the previous year.
We also awarded more member support grants; a total of 552 grants were awarded which was a 30% increase on 2023.
Service · Observational claim · From Debra — annual report and accounts, year ending 31 December 2024, page 6
DEBRA supported more individuals in 2024 with an 8% increase in support from the EB Community Support Team compared to 2023.
During the year we supported more members than ever before; 673 individuals received support from our EB Community Support Team, which was an 8% increase on 2023.
Service · Observational claim · From Debra — annual report and accounts, year ending 31 December 2024, page 6
The Social Housing Pension Scheme is classified as a 'last-man standing arrangement'.
The Scheme is classified as a ‘last-man standing arrangement’. Therefore the company is potentially liable for other participating employers’ obligations if those employers are unable to meet their share of the scheme deficit following withdrawal from the Scheme.
Financial · Observational claim · From Southside Partnership — annual report and accounts, year ending 31 March 2025, page 42
Southside Partnership holds £978,080 in trust for clients at the end of March 2025.
At end of March 2025, Southside Partnership Ltd was holding a total sum of £978,080 (2024: £1,269,836) on trust in relation to clients.
Financial · Observational claim · From Southside Partnership — annual report and accounts, year ending 31 March 2025, page 45
Southside Partnership is wholly owned by Certitude Support Limited, a Registered Society.
Southside Partnership is a wholly owned subsidiary of Certitude Support Limited, a Registered Society with registration number 30891R which is the ultimate controlling party.
Governance · Observational claim · From Southside Partnership — annual report and accounts, year ending 31 March 2025, page 44
The Social Housing Pension Scheme has a deficit of £693m as per the last triennial valuation.
This valuation revealed a deficit of £693m.
Financial · Observational claim · From Southside Partnership — annual report and accounts, year ending 31 March 2025, page 42